Design of novel antituberculosis compounds using graph-theoretical and substructural approaches

Molecular Diversity

Volumn 13, Issue 4, 2009, Pages 445-458

  Planche, Alejandro Speck ^a,b   Scotti, Marcus Tulius ^c   López, América García ^a   De Paulo Emerenciano, Vicente ^b   Pérez, Enrique Molina ^d   Uriarte, Eugenio ^e  

^a UNIVERSIDAD DE ORIENTE   (Cuba)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^d UNIVERSIDAD DE CAMAGÜEY   (Cuba)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Antituberculosis; Discriminant analysis; Fragment contributions; Graph theoretical descriptors; Massive screening

Indexed keywords

CLOTRIMAZOLE; ECONAZOLE; IMIDAZOLE DERIVATIVE; MICONAZOLE; NICLOSAMIDE; PYRIMETHAMINE; TUBERCULOSTATIC AGENT;

COMPUTER MODEL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANTITUBERCULAR AGENTS; DRUG DESIGN; MODELS, MOLECULAR; ROC CURVE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349904699     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11030-009-9129-9     Document Type: Review

References (86)

1. DL Cohn F Bustreo MC Raviglione 1997 Drug resistant tuberculosis: review of the worldwide situation and WHO/IUATLD Global Surveillance Project. International Union against Tuberculosis and Lung Disease Clin Infect Dis 24 121 130
2. World Health Organization Report Available at http://www.who.int/tb/en/
3. Hansch C, Leo A (1995) QSAR: fundamentals and applications in chemistry and biology. American Chemical Society, Washington, DC
4. Kubinyi H (1993) QSAR: Hansch analysis and related approaches. VCH, New York
5. Kier LB, Hall LH (1976) Molecular connectivity in chemistry and drug research. Academic, New York
6. Kier LB, Hall LH (1986) Molecular connectivity in structure-activity analysis. Research Studies, Letchworth, Herts
7. R García-Domenech FJ García RM Soler J Gálvez GM Anton-Fos JV de Julián-Ortiz 1996 New analgesics design by molecular topology Quant Struc-Act Rel 15 1 7 10.1002/qsar.19960150102 10.1002/qsar.19960150102 (Pubitemid 26072213)
8. JV de Julián-Ortiz J Gálvez C Muñoz-Collado R García-Domenech C Gimeno-Cardona 1999 Virtual combinatorial synthesis and computational screening of new potential anti-herpes compounds J Med Chem 42 3308 3314 10.1021/jm981132u 10464017 10.1021/jm981132u (Pubitemid 29409719)
9. C de Gregorio Alapont R García-Domenech J Gálvez MJ Ros S Wolski MD García 2000 Molecular topology: a useful tool for the search of new antibacterials Bioorg Med Chem Lett 10 2033 2036 10.1016/S0960-894X(00) 00406-6 10987443 10.1016/S0960-894X(00)00406-6 (Pubitemid 30663366)
10. R Gozalbes M Brun-Pascaud J Gálvez R García-Domenech PM Girard JP Doucet, et al. 2000 Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening Antimicrob Agents Chemother 44 2764 2770 10.1128/AAC.44.10.2764-2770.2000 10991858 10.1128/AAC.44.10.2764-2770.2000 1:CAS:528:DC%2BD3cXmvVyqt7g%3D (Pubitemid 30737697)
11. H Kubinyi OH Kehrhahn 1976 Quantitative structure-activity relationships. 1. The modified Free-Wilson approach J Med Chem 19 578 586 10.1021/jm00227a003 1271399 10.1021/jm00227a003 1:CAS:528:DyaE28XhsVCgtrk%3D
12. H Kubinyi 1976 Quantitative structure-activity relationships. 2. A mixed approach, based on Hansch and Free-Wilson analysis J Med Chem 19 587 600 10.1021/jm00227a004 818381 10.1021/jm00227a004 1:CAS:528:DyaE28XhsVCmtL4%3D
13. JA Kiritsy DK Yung DE Mahony 1978 Synthesis and quantitative structure-activity relationships of some antibacterial 3-formylrifamycin SV N-(4-substituted phenyl)piperazinoacethydrazones J Med Chem 21 1301 1307 10.1021/jm00210a025 722738 10.1021/jm00210a025 1:CAS:528:DyaE1MXotFCnsw%3D%3D
14. KF Pasqualoto EI Ferreira OA Santos-Filho AJ Hopfinger 2004 Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives J Med Chem 47 3755 3764 10.1021/jm049913k 15239654 10.1021/jm049913k 1:CAS:528:DC%2BD2cXkvVSjur8%3D (Pubitemid 38900342)
15. B Desai D Sureja Y Naliapara A Shah AK Saxena 2001 Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents Bioorg Med Chem 9 1993 1998 10.1016/S0968-0896(01)00141-9 11504636 10.1016/S0968- 0896(01)00141-9 1:CAS:528:DC%2BD3MXlvFWiurw%3D (Pubitemid 32739187)
16. A Gallegos R Carbo-Dorca R Ponec K Waisser 2004 Similarity approach to QSAR: application to antimycobacterial benzoxazines Int J Pharm 269 51 60 10.1016/j.ijpharm.2003.08.013 14698576 10.1016/j.ijpharm.2003.08.013 1:CAS:528:DC%2BD3sXpvFeksb8%3D (Pubitemid 38032822)
17. R Ragno GR Marshall R Di Santo R Costi S Massa R Rompei, et al. 2000 Antimycobacterial pyrroles: synthesis, anti-Mycobactrium tuberculosis activity and QSAR studies Bioorg Med Chem 8 1423 1432 10.1016/S0968-0896(00)00061-4 10896119 10.1016/S0968-0896(00)00061-4 1:CAS:528:DC%2BD3cXksFCrsbg%3D (Pubitemid 30398462)
18. WJ Suling JA Maddry 2001 Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro J Antimicrob Chemother 47 451 454 10.1093/jac/47.4.451 11266419 10.1093/jac/47.4.451 1:CAS:528: DC%2BD3MXjtVamurw%3D
19. E Besalu R Ponec JV de Julián-Ortiz 2003 Virtual generation of agents against Mycobacterium tuberculosis Mol Divers 6 107 120 10.1023/B:MODI.0000006839.52374.d7 14761161 10.1023/B:MODI.0000006839.52374.d7 1:CAS:528:DC%2BD3sXpsFOnsrk%3D (Pubitemid 38094861)
20. A García-García J Galvez JV de Julián-Ortiz R García-Domenech C Muños R Guna, et al. 2005 Search of chemical scaffolds for novel antituberculosis agents J Biomol Screen 10 206 214 10.1177/1087057104273486 15809316 10.1177/1087057104273486 (Pubitemid 40617158)
21. E Estrada E Molina 2001 Novel local (fragment-based) topological molecular descriptors for QSPR/QSAR and molecular design J Mol Graph Model 20 54 64 10.1016/S1093-3263(01)00100-0 11760003 10.1016/S1093-3263(01)00100-0 1:CAS:528:DC%2BD3MXntlyjtbs%3D (Pubitemid 32938503)
22. VN Viswanadhan AK Ghose GR Revankar RK Robins 1989 Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics J Chem Inf Comput Sci 29 163 172 10.1021/ci00063a006 1:CAS:528:DyaL1MXkslSgs7w%3D
23. VN Viswanadhan MR Reddy RJ Bacquet MD Erion 1993 Assessment of methods used for predicting lipophilicity: application to nucleosides and nucleoside bases J Comput Chem 14 1019 1026 10.1002/jcc.540140903 10.1002/jcc.540140903 1:CAS:528:DyaK3sXlvF2is7s%3D
24. B Zagrovic WF van Gunsteren 2007 Computational analysis of the mechanism and thermodynamics of inhibition of phophodiesterase 5A by synthetic ligands J Chem Theory Comput 3 301 311 10.1021/ct600322d 10.1021/ct600322d 1:CAS:528:DC%2BD28Xhtlahsb%2FO
25. U Bren V Martínek J Florián 2006 Free energy simulations of uncatalized DNA replication fidelity: structure and stability of T•G and dTTP• G terminal DNA mismatches flanked by a single dangling nucleotide J Phys Chem B 110 10557 10566 10.1021/jp060292b 16722767 10.1021/jp060292b 1:CAS:528:DC%2BD28XktVyqs78%3D (Pubitemid 43952953)
26. E Estrada 1996 Spectral moments of the edge adjacency matrix in molecular graphs. 1. Definition and applications for the prediction of physical properties of alkanes J Chem Inf Comput Sci 36 844 849 10.1021/ci950187r 1:CAS:528:DyaK28XjvFWlu70%3D
27. E Estrada 1997 Spectral moments of the edge adjacency matrix in molecular graphs. 2. Molecules containing heteroatoms and QSAR applications J Chem Inf Comput Sci 37 320 328 10.1021/ci960113v 1:CAS:528:DyaK2sXhvVSktbw%3D
28. E Estrada 1998 Spectral moments of the edge adjacency matrix in molecular graphs. 3. Molecules containing cycles J Chem Inf Comput Sci 38 23 27 10.1021/ci970030u 1:CAS:528:DyaK1cXmsV2m
29. E Estrada 1998 Modeling the diamagnetic susceptibilities of organic compounds by a substructural graph theoretical approach J Chem Soc, Faraday Trans 94 1407 1411 10.1039/a709032c 10.1039/a709032c 1:CAS:528: DyaK1cXjtVags7o%3D
30. E Estrada 1999 Generalized spectral moments of the interacted line graph sequence A novel approach to QSPR Studies. J Chem Inf Comput Sci 39 90 95 10.1021/ci9800460 1:CAS:528:DyaK1MXhtVamug%3D%3D
31. E Estrada A Peña R García-Domenech 1998 Designing sedative/hypnotic compounds from a novel structural graph theoretical-approach J Comput Aided Mol Des 12 583 595 10.1023/A:1008048003720 9879506 10.1023/A:1008048003720 1:CAS:528:DyaK1MXjslWquw%3D%3D
32. E Estrada Y Gutiérrez 1999 Modeling chromatographic parameters by a novel graph theoretical sub-structural approach J Chromatogr A 858 187 199 10.1016/S0021-9673(99)00808-0 10551351 10.1016/S0021-9673(99)00808-0 1:CAS:528:DyaK1MXmsVWhu7c%3D (Pubitemid 29450472)
33. E Estrada Y Gutiérrez H González 2000 Modeling diamagnetic and magnetooptic properties of organic compounds with the TOSS-MODE approach J Chem Inf Comput Sci 40 1386 1399 10.1021/ci000041e 11128097 1:CAS:528: DC%2BD3cXmtlalt7o%3D
34. E Estrada A Peña 2000 In silico studies for the rational discovery of anticonvulsant Compounds Bioorg Med Chem 8 2755 2770 10.1016/S0968-0896(00) 00204-2 11131167 10.1016/S0968-0896(00)00204-2 1:CAS:528:DC%2BD3cXot12mtb4%3D (Pubitemid 30838101)
35. E Estrada E Uriarte A Montero M Tejeira L Santana E De Clercq 2000 A novel approach to the rational selection and design of anticancer compounds J Med Chem 43 1975 1985 10.1021/jm991172d 10821710 10.1021/jm991172d 1:CAS:528:DC%2BD3cXis1Whurg%3D (Pubitemid 30340937)
36. M Pérez-González H González-Díaz R Molina MA Cabrera RA Ramos 2003 TOPS-MODE based QSARs derived from heterogeneous series of compounds Applications to the design of new herbicides. J Chem Inf Comput Sci 43 1192 1199 10.1021/ci034039+
37. E Estrada 1995 Edge adjacency relationship and a novel topological index related to molecular volume J Chem Inf Comput Sci 35 31 33 10.1021/ci00023a004 1:CAS:528:DyaK2MXjt1ygtrg%3D
38. E Estrada E Uriarte 2001 Quantitative structure-toxicity relationship using TOPS-MODE. 1. Nitrobenzene toxicity to Tetrahymena pyriformis SAR QSAR Environ Res 12 309 324 10.1080/10629360108032919 11696927 10.1080/ 10629360108032919 1:CAS:528:DC%2BD3MXnslGitbw%3D
39. E Estrada E Molina E Uriarte 2001 Quantitative structure-toxicity relationship using TOPS-MODE. 2. Neurotoxicity of a noncongeneric series of solvents SAR QSAR Environ Res 12 445 459 10.1080/10629360108035384 11813810 10.1080/10629360108035384 1:CAS:528:DC%2BD38XkvFSmtQ%3D%3D
40. E Estrada E Uriarte 2001 Recent advances on the role of topological indices in drug discovery research Curr Med Chem 8 1573 1588 11562286 1:CAS:528:DC%2BD3MXosV2gtbg%3D
41. LB Kier LH Hall 1981 Derivation and significance of valence molecular connectivity J Pharm Sci 70 583 589 10.1002/jps.2600700602 7252795 10.1002/jps.2600700602 1:CAS:528:DyaL3MXltFCmt7g%3D (Pubitemid 11035281)
42. J Galvez 1998 On a topological interpretation of electronic and vibrational molecular energies J Mol Struct THEOCHEM 429 255 264 10.1016/S0166-1280(97)00366-7 10.1016/S0166-1280(97)00366-7 1:CAS:528: DyaK1cXitVKquro%3D
43. E Estrada 1999 Connectivity polynomial and long-range contributions in the molecular connectivity model Chem Phys Lett 312 556 560 10.1016/S0009- 2614(99)01007-6 10.1016/S0009-2614(99)01007-6 1:CAS:528:DC%2BD3cXhs1em
44. LB Kier LH Hall 2000 The e-state as the basis for molecular structure space definition and structure similarity J Chem Inf Comput Sci 40 784 791 10.1021/ci990140w 10850783
45. M Petitjean 1992 Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds J Chem Inf Comput Sci 32 331 337 10.1021/ci00008a012 1:CAS:528:DyaK38Xks12hsrk%3D
46. E Estrada E Molina I Perdomo-López 2001 Can 3D structural parameters be predicted from 2D (topological) molecular descriptors? J Chem Inf Comput Sci 41 1015 1021 10.1021/ci000170v 11500118 1:CAS:528: DC%2BD3MXkt1ers78%3D
47. PA Bath AR Poirrete P Willett 1995 The extent of the relationship between the graph-theoretical and the geometrical shape coefficients of chemical compounds J Chem Inf Comput Sci 35 714 716 10.1021/ci00026a007 1:CAS:528:DyaK2MXms1KqtLk%3D
48. A Montero-Torres MC Vega Y Marrero-Ponce M Rolón A Gómez-Barrio JA Escario, et al. 2005 A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal compounds Bioorg Med Chem 13 6264 6275 10.1016/j.bmc.2005.06. 049 16115770 10.1016/j.bmc.2005.06.049 1:CAS:528:DC%2BD2MXhtVynur7F (Pubitemid 41400149)
49. Y Marrero-Ponce M Iyarreta-Veitía A Montero-Torres C Romero-Zaldívar CA Brandt P Ávila, et al. 2005 Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps J Chem Inf Model 45 1082 1100 10.1021/ci050085t 16045304 10.1021/ci050085t 1:CAS:528: DC%2BD2MXkvVGltLk%3D (Pubitemid 41156709)
50. H González-Díaz FJ Prado-Prado L Santana E Uriarte 2006 Unify QSAR approach to antimicrobials Part 1 predicting antifungal activity against different species Bioorg Med Chem 1459735980 10.1016/j.bmc.2006.05.018 (Pubitemid 44080581)
51. FJ Prado-Prado H González-Díaz L Santana E Uriarte 2007 Unify QSAR approach to antimicrobials Part 2 predicting activity against more than 90 different species in order to halt antibacterial resistance Bioorg Med Chem 15897902 10.1016/j.bmc.2006.10.039 (Pubitemid 44880716)
52. M Randić 1975 Characterization of molecular branching J Am Chem Soc 97 6609 6615 10.1021/ja00856a001 10.1021/ja00856a001
53. E Estrada S Vilar E Uriarte Y Gutierrez 2002 In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives J Chem Inf Comput Sci 42 1194 1203 10.1021/ci0255331 12377009 1:CAS:528:DC%2BD38XlsFKmsrg%3D (Pubitemid 35360305)
54. BD Gute K Balasubramanian KT Geiss SC Basak 2004 Prediction of halocarbon toxicity from structure: a hierarchical QSAR approach Environ Toxicol Pharmacol 16 121 129 10.1016/j.etap.2003.10.005 10.1016/j.etap.2003.10.005 1:CAS:528:DC%2BD2cXhslWltLk%3D (Pubitemid 38314899)
55. M Randić 2001 The connectivity index 25 years after J Mol Graph Model 20 19 35 10.1016/S1093-3263(01)00098-5 11760000 10.1016/S1093-3263(01) 00098-5 (Pubitemid 32938276)
56. V Consonni R Todeschini M Pavan 2002 Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 1. Theory of the novel 3D molecular descriptors J Chem Inf Comput Sci 42 682 692 10.1021/ci015504a 12086530 1:CAS:528:DC%2BD38XivFCgtrY%3D (Pubitemid 35355277)
57. V Consonni R Todeschini M Pavan P Gramatica 2002 Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 2. Application of the novel 3D molecular descriptors to QSAR/QSPR studies J Chem Inf Comput Sci 42 693 705 10.1021/ci0155053 12086531 1:CAS:528: DC%2BD38XivFCgtrc%3D (Pubitemid 35355278)
58. 2 A adenosine receptors agonists Eur J Med Chem 40 1080 1086 10.1016/j.ejmech.2005. 04.014 10.1016/j.ejmech.2005.04.014 (Pubitemid 41446277)
59. A Hocquet M Langgård 1998 An evaluation of the MM+ force field J Mol Model 4 94 112 10.1007/s008940050128 10.1007/s008940050128 1:CAS:528:DyaK1cXjtlajs7g%3D
60. MJS Dewar EG Zoebisch EF Healy JJP Stewart 1985 The development and use of quantum-mechanical molecular-models. 76. AM1 - a new general-purpose quantum-mechanical molecular-model J Am Chem Soc 107 3902 3909 10.1021/ja00299a024 10.1021/ja00299a024 1:CAS:528:DyaL2MXktFWlsLk%3D
61. MH Abraham 1993 Scales of solute hydrogen-bonding: their construction and application to physicochemicaI and biochemicaI processes Chem Soc Rev 22 73 83 10.1039/cs9932200073 10.1039/cs9932200073 1:CAS:528:DyaK3sXktlGjt7s%3D
62. JA Platts D Butina MH Abraham A Hersey 1999 Estimation of molecular linear free energy relation descriptors using a group contribution approach J Chem Inf Comput Sci 39 835 845 10.1021/ci980339t 1:CAS:528:DyaK1MXksFGitrw%3D
63. U Bren V Martínek J Florian 2006 Free energy simulations of uncatalyzed DNA replication fidelity: structure and stability of T.G and dTTP.G terminal DNA mismatches flanked by a single dangling nucleotide J Phys Chem B 110 10557 10566 10.1021/jp060292b 16722767 10.1021/jp060292b 1:CAS:528:DC%2BD28XktVyqs78%3D (Pubitemid 43952953)
64. JB Klauda BR Brooks 2007 Sugar binding in lactose permease: anomeric state of a disaccharide influences binding structure J Mol Biol 367 1523 1534 10.1016/j.jmb.2007.02.001 17320103 10.1016/j.jmb.2007.02.001 1:CAS:528:DC%2BD2sXjtFKiur8%3D (Pubitemid 46413278)
65. B Zagrovic WF van Gunsteren 2007 Computational analysis of the mechanism and thermodynamics of inhibition of phosphodiesterase 5A by synthetic ligands J Chem Theory Comput 3 301 311 10.1021/ct600322d 10.1021/ct600322d 1:CAS:528:DC%2BD28Xhtlahsb%2FO
66. Kowalski RB, Wold S (1982) Pattern recognition in chemistry. In: Krishnaiah PR, Kanal LN (eds) Handbook of statistic. North Holland, Amsterdam, pp 673-697
67. McFarland JW, Gans DJ (1995) Cluster significance analysis. In: Manhnhold R, Krogsgaard-Larsen P, Timmerman H, Van Waterbeemd H (eds) Methods and principles in medicinal chemistry, vol 2, Chemometric methods in molecular design. VCH, Weinhiem, pp 295-308
68. Johnson RA, Wichern DW (1998) Applied multivariate statistical analysis. Prentice-Hall, NJ
69. Fawcett T (2004) ROC Graphs: notes and practical considerations for researchers. Technical report, Palo Alto, HP Laboratories USA
70. JA Hanley BJ McNeil 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 29 36 7063747 1:STN:280:DyaL387ltFyksQ%3D%3D
71. R Li R Sirawaraporn P Chitnumsub W Sirawaraporn J Wooden F Athappilly, et al. 2000 Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs J Mol Biol 295 307 323 10.1006/jmbi.1999.3328 10623528 10.1006/jmbi.1999.3328 1:CAS:528:DC%2BD3cXht1Cksg%3D%3D (Pubitemid 30045362)
72. LM Podust TL Poulos MR Waterman 2001 Crystal structure of cytochrome P450 14α-sterol demethylase (CyP51) from Mycobacterium tuberculosis in complex with azole inhibitors Proc Natl Acad Sci USA 98 3068 3073 10.1073/pnas. 061562898 11248033 10.1073/pnas.061562898 1:CAS:528:DC%2BD3MXit1amu7Y%3D (Pubitemid 32220800)
73. CW Goulding A Parseghian MR Sawaya D Cascio MI Apostol ML Gennaro, et al. 2002 Crystal structure of a major secreted protein of Mycobacterium tuberculosis-MPT63 at 1.5-Å resolution Protein Sci 11 2887 2893 10.1110/ps.0219002 12441386 10.1110/ps.0219002 1:CAS:528:DC%2BD38XptVeksr0%3D (Pubitemid 35365254)
74. H Lu PJ Tonge 2008 Inhibitors of FabI, drug target in the bacterial fatty acid biosynthesis pathway Acc Chem Res 41 11 20 10.1021/ar700156e 18193820 10.1021/ar700156e 1:CAS:528:DC%2BD1cXlsl2ksA%3D%3D
75. K Matsuura S Yoshioka T Tosha H Hori K Ishimori T Kitagawa, et al. 2005 Structural diversities of active site in clinical azole-bound forms between sterol 14α-demethylase (CYP51s) from Human and Mycobacterium tuberculosis J Biol Chem 280 9088 9096 10.1074/jbc.M413042200 15611056 10.1074/jbc.M413042200 1:CAS:528:DC%2BD2MXitVCitLw%3D (Pubitemid 40409603)
76. MK Spigelman 2007 New tuberculosis therapeutics: a growing pipeline JID 196 28 34 10.1086/518663 10.1086/518663 (Pubitemid 47206082)
77. R Maccari R Ottaná MG Vigorita 2005 In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides, and cyanoboranes: Part 14 Bioorg Med Chem Lett 15 2509 2513 10.1016/j.bmcl.2005.03. 065 15863306 10.1016/j.bmcl.2005.03.065 1:CAS:528:DC%2BD2MXjslyrtbg%3D (Pubitemid 40614979)
78. KK Bedia O Elçin U Seda K Fatma S Nathaly R Sevim, et al. 2006 Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity Eur J Med Chem 41 1253 1261 10.1016/j.ejmech.2006.06.009 16919372 10.1016/j.ejmech.2006.06.009 1:CAS:528:DC%2BD28XhtFyltr7L (Pubitemid 44755094)
79. CK Stover P Warrener DR VanDevanter DR Sherman TM Arain MH Langhorne, et al. 2000 A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis Nature 45 962 966 10.1038/35016103 10.1038/35016103 (Pubitemid 30435054)
80. MA Cabrera I González C Fernández C Navarro M Bermejo 2006 A topological substructural approach for the prediction of p-glycoprotein substrates J Pharm Sci 95 589 606 10.1002/jps.20449 16432877 10.1002/jps.20449 1:CAS:528:DC%2BD28XisVSqtrs%3D
81. E Estrada 2002 Physicochemical interpretation of molecular connectivity indices J Phys Chem 106 9085 9091 1:CAS:528:DC%2BD38XmsVOisr4%3D
82. Van Waterbeemd H (1995) Discriminant analysis for activity prediction. In: Manhnhold R, Krogsgaard-Larsen P, Timmerman H, Waterbeemd H (eds) Methods and principles in medicinal chemistry, vol 2, Chemometric methods in molecular design. VCH, Weinhiem, pp 295-308
83. L De Luca 2006 Naturally occurring and synthetic imidazoles: their chemistry and their biological activity Curr Med Chem 13 1 23 10.2174/092986706775197980 16457636 10.2174/092986706775197980 1:CAS:528:DC%2BD28XisVShsA%3D%3D
84. Huesca M, Al-Qawasmeh R, Young AH, Lee Y (2005) Patent WO 2005/047266 A1, International Application Number PCT/IB2004/052433
85. Huesca M, Al-Qawasmeh R, Young AH, Lee Y (2004) Patent WO 2004/016086 A2, International Application Number PCT/CA2003/001229
86. MS Khan SA Siddiqui MSRA Siddiqui U Goswami KV Srinivasan MI Khan 2008 Antibacterial activity of synthetisized 2,4,5-trisubstituted imidazole derivatives Chem Biol Drug Des 72 197 204 10.1111/j.1747-0285.2008.00691.x 18680533 10.1111/j.1747-0285.2008.00691.x 1:CAS:528:DC%2BD1cXhtFKgsLbE